Clinical trial
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
NCT01853085 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2013
- Completion date
- March 1, 2014
- Enrollment
- 1,830 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma, primary open angle, ocular hypertension